Results 51 to 60 of about 3,021 (239)
Asian Journal of Transfusion Science, 2016 In this study we have evaluated the various adverse reactions related to transfusion occurring in our institution as a pilot institutional effort toward a hemovigilance program. This study will also help in understanding the problems faced by blood banks/Transfusion Medicine departments in implementing an effective hemovigilance program.All the adverse
Rahul Vasudev +3 more
openaire +3 more sources
Donor hemovigilance: a call to arms [PDF]
Transfusion, 2020 See article on page 1231–1242, in this ...
openaire +2 more sources
Health technology assessment of pathogen reduction technologies applied to plasma for clinical use [PDF]
, 2016 Although existing clinical evidence shows that the transfusion of blood components is becoming increasingly safe, the risk of transmission of known and unknown pathogens, new pathogens or re-emerging pathogens still persists.
Berrino, Alexandra +18 more
core +1 more source
Transfusion, 2023 France converted to universal pathogen reduced (PR; amotosalen/UVA) platelets in 2017 and extended platelet component (PC) shelf‐life from 5‐ to 7‐days in 2018 and 2019. Annual national hemovigilance (HV) reports characterized longitudinal PC utilization
J. Pitman +5 more
semanticscholar +1 more source
Overview of the French Hemovigilance [PDF]
Transfusion Alternatives in Transfusion Medicine, 2003 SUMMARyHemovigilance began in France in 1993 and was reorganized in 1998.The Hemovigilance Unit is now part of the drug security agency (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) and has recently published its annual report. The number of deaths related to transfusion is decreasing but still significant (45 in 2001). Causes
Jean‐Luc Wautier, Claudine Hossenlopp
openaire +1 more source
Characteristics and incidence of transfusion-associated necrotizing enterocolitis in the UK [PDF]
, 2018 BACKGROUND AND AIMS: The etiology of necrotizing enterocolitis (NEC) is unclear and postulated as being multifactorial. It has been suggested that one causative factor is the transfusion of packed red blood cells (PRBCs) leading to the disease entity ...
Cherian, Shobha +9 more
core +2 more sources
Mirasol PRT system inactivation efficacy evaluated in platelet concentrates by bacteria-contamination model [PDF]
, 2011 Background/Aim. Bacterial contamination of blood components, primarily platelet concentrates (PCs), has been identified as one of the most frequent infectious complications in transfusion practice.
Balint Bela +5 more
core +1 more source
Retrospective Evaluation of Cryoprecipitate Transfusion in Dogs to Prevent or Treat Hemorrhage: 21 Cases (2009-2023). [PDF]
J Vet Emerg Crit Care (San Antonio)ABSTRACT Objective To report homologous cryoprecipitate transfusions in dogs with hemostatic disorders, hemorrhage, or risk of hemorrhage, and to report adverse reactions associated with these cryoprecipitate transfusions. Design Retrospective case series (July 2009 to July 2023). Setting University teaching hospital.
Lam WYE +3 more
europepmc +2 more sources
Transfusion-transmitted malaria: donor prevalence of parasitaemia and a survey of healthcare workers knowledge and practices in a district hospital in Ghana [PDF]
, 2016 Background Transfusion-transmitted malaria (TTM) is a risk of transfusion that has not been well described in malaria endemic regions. The risk of the recipient getting malaria is related to the prevalence of malaria in the blood donors.
Bates, Imelda +2 more
core +2 more sources
National Journal of Physiology, Pharmacy and Pharmacology, 2020 Background: Blood transfusion is a lifesaving procedure but has potential to cause adverse events. Hemovigilance is a program that ensures safety of transfusion reactions by monitoring every step of transfusion process from donor to recipient.
Rukhsana Chowdhary +2 more
doaj +1 more source